超声识别膝关节焦磷酸钙晶体沉积的标准效度:一项OMERACT超声研究
该研究以膝关节置换术患者的半月板和透明软骨显微镜分析为参考标准,评估超声对焦磷酸钙沉积病(CPPD)的判别能力,纳入68例分析。超声诊断CPPD总体准确率75%,敏感度91%、特异度59%,联合评估内侧半月板与内侧髁透明软骨时敏感度88%、特异度76%;有无CPPD患者的超声炎症征象无差异。
要点
- 超声诊断膝关节CPPD总体敏感度91%、特异度59%,准确率75%。
- 联合评估内侧半月板与内侧髁透明软骨敏感度88%、特异度76%。
- 有无CPPD患者的超声炎症征象(积液、滑膜增生、能量多普勒)无差异。
核心结论
- 超声是判别膝关节焦磷酸钙沉积病的准确工具。
- 单纯骨关节炎与CPPD合并骨关节炎患者的超声炎症征象无差异。
研究设计与样本
- 连续纳入因骨关节炎拟行膝关节置换术的患者,行膝关节半月板与透明软骨超声检查并评分CPPD存在与否。
- 手术获取的半月板与髁部标本经光学显微镜及补偿偏振光显微镜检查,在六个不同样本中评分CPPD存在与否。
- 超声与显微镜分析由不同操作者盲法完成;101例入组患者中68例纳入分析,38例手术标本不足。
主要发现
- 超声诊断CPPD总体准确率75%,敏感度91%(单部位范围71%-87%),特异度59%(范围68%-92%)。
- 联合评估内侧半月板与内侧髁透明软骨时敏感度88%、特异度76%,为最佳组合。
- 有无CPPD患者之间超声炎症征象无差异。
关键数值与推荐
- 超声诊断CPPD总体敏感度91%、特异度59%、准确率75%。
- 联合内侧半月板与内侧髁透明软骨评估敏感度88%、特异度76%。
临床怎么用
- 超声可用于膝关节CPPD的判别,联合评估内侧半月板与内侧髁透明软骨可优化诊断表现。
- 超声炎症征象不能区分单纯骨关节炎与CPPD合并骨关节炎。
局限性
- 101例入组患者中38例因手术标本不足未纳入分析。
- 单部位敏感度与特异度范围较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the discriminatory ability of ultrasound in calcium pyrophosphate deposition disease (CPPD), using microscopic analysis of menisci and knee hyaline cartilage (HC) as reference standard. METHODS: Consecutive patients scheduled for knee replacement surgery, due to osteoarthritis (OA), were enrolled. Each patient underwent ultrasound examination of the menisci and HC of the knee, scoring each site for presence/absence of CPPD. Ultrasound signs of inflammation (effusion, synovial proliferation and power Doppler) were assessed semiquantitatively (0-3). The menisci and condyles, retrieved during surgery, were examined microscopically by optical light microscopy and by compensated polarised microscopy. CPPs were scored as present/absent in six different samples from the surface and from the internal part of menisci and cartilage. Ultrasound and microscopic analysis were performed by different operators, blinded to each other's findings. RESULTS: 11 researchers from seven countries participated in the study. Of 101 enrolled patients, 68 were included in the analysis. In 38 patients, the surgical specimens were insufficient. The overall diagnostic accuracy of ultrasound for CPPD was of 75%-sensitivity of 91% (range 71%-87% in single sites) and specificity of 59% (range 68%-92%). The best sensitivity and specificity were obtained by assessing in combination by ultrasound the medial meniscus and the medial condyle HC (88% and 76%, respectively). No differences were found between patients with and without CPPD regarding ultrasound signs of inflammation. CONCLUSION: Ultrasound demonstrated to be an accurate tool for discriminating CPPD. No differences were found between patents with OA alone and CPPD plus OA regarding inflammation.
引用
- Filippou G, Scanu A, Adinolfi A, et al. Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study. Ann Rheum Dis. 2020. PMID: 32988839. doi:10.1136/annrheumdis-2020-217998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。